Lymphoplus Liquid
NDC Package 43742-0949-1
Package Information
Lymphoplus (trifolium pratense, lymph node (suis), spleen (suis), conium maculatum, echinacea (angustifolia), lycopodium clavatum, myrrha, phytolacca decandra, selenium metallicum, silicea) liquids is for the temporary relief of symptoms related to impaired function of the lymphatic system including fever, earache, and cough.****These statements are based upon homeopathic principles. This formulation utilizes a liquid delivery system. Marketed by Deseret Biologicals, Inc., this product is identified by NDC 43742-0949.
Identification & Billing
Clinical Specifications
- CONIUM MACULATUM FLOWERING TOP 12 [hp_X]/mL
- ECHINACEA ANGUSTIFOLIA WHOLE 12 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/mL
- MYRRH 12 [hp_X]/mL
- PHYTOLACCA AMERICANA ROOT 12 [hp_X]/mL
- SELENIUM 12 [hp_X]/mL
- SILICON DIOXIDE 12 [hp_X]/mL
- SUS SCROFA LYMPH 8 [hp_X]/mL
- SUS SCROFA SPLEEN 8 [hp_X]/mL
- TRIFOLIUM PRATENSE FLOWER 3 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 43742 - Deseret Biologicals, Inc.
- 43742-0949 - Lymphoplus
- 43742-0949-1 - 30 mL in 1 BOTTLE, DROPPER
- 43742-0949 - Lymphoplus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43742-0949-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Lymphoplus, a human over the counter drug labeled by Deseret Biologicals, Inc.. This liquid is formulated for oral use and contains conium maculatum flowering top; echinacea angustifolia whole; lycopodium clavatum spore; myrrh; phytolacca americana root; selenium; silicon dioxide; sus scrofa lymph; sus scrofa spleen; trifolium pratense flower as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deseret Biologicals, Inc. on December 29, 2016. The current certification is valid through December 31, 2026.
How is this Deseret Biologicals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43742094901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.